Klow Peptide Blend 80mg : BPC-157, GHK-Cu, TB-500 & KPV

£80.00

KLOW 80 mg Peptide Blend

Pack 1 vial x 80 mg lyophilized (freeze-dried) powder.

Note:  The following lab supplies are required for reconstitution: bacteriostatic water for mixing, and syringes to draw from the vials.

Description

Estimated delivery 1-2 weeks

Products are shipping without brand labels for security reasons.

The KLOW Blend is an advanced, multi-action peptide stack often used in regenerative medicine and wellness to accelerate tissue repair, reduce inflammation, and promote cellular renewal. It combines four distinct synthetic peptides into one coordinated protocol: [1, 2, 3]
    • GHK-Cu (50 mg): Promotes collagen production, improves skin elasticity, and supports cellular regeneration.
    • BPC-157 (10 mg): Often referred to as the “healing peptide,” it targets muscle, tendon, ligament, and gut lining repair.
    • TB-500 (10 mg): Enhances flexibility, accelerates muscle recovery, and supports overall tissue resilience.
    • KPV (10 mg): Acts as a potent anti-inflammatory and helps balance the immune response from the inside out. [1, 2, 3]
Key Benefits and Considerations
  • Tissue Healing: Used frequently for post-injury recovery, athletic performance, and anti-aging/skin revitalization.

This multi-peptide blend provides synergistic regenerative, anti-inflammatory, and tissue-repair support. The following titration schedule allows gradual introduction of each component.

WEEK DAILY DOSE (PER COMPONENT) UNITS (PER INJECTION) (ML)
Weeks 1–2 TB-500: 250 mcg | BPC-157: 250 mcg | KPV: 250 mcg | GHK-Cu: 1.25 mg 7.5 units (0.075 mL)
Weeks 3–4 TB-500: 500 mcg | BPC-157: 500 mcg | KPV: 500 mcg | GHK-Cu: 2.5 mg 15 units (0.15 mL)
Weeks 5–8 TB-500: 750 mcg | BPC-157: 750 mcg | KPV: 750 mcg | GHK-Cu: 3.75 mg 22.5 units (0.225 mL)
Weeks 9–12 (Maintenance) TB-500: 500 mcg | BPC-157: 500 mcg | KPV: 500 mcg | GHK-Cu: 2.5 mg 15 units (0.15 mL)

Frequency: Inject once daily subcutaneously. This schedule uses a 3.0 mL dilution to maintain measurable volumes. For ≤10-unit (≤0.10 mL) administrations during initial weeks, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall; avoid foaming.
  3. Gently swirl/roll until dissolved (do not shake).
  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Syringe Math Reference

With 3.0 mL reconstitution volume and 80 mg total peptide:

  • Total concentration: 26.67 mg/mL (26,667 mcg/mL)
  • TB-500: 3.33 mg/mL → 33.3 mcg per unit
  • BPC-157: 3.33 mg/mL → 33.3 mcg per unit
  • KPV: 3.33 mg/mL → 33.3 mcg per unit
  • GHK-Cu: 16.67 mg/mL → 166.7 mcg per unit
  • 1 unit (0.01 mL) = 33.3 mcg each of TB-500, BPC-157, KPV + 166.7 mcg GHK-Cu

Plan based on an 8–16 week daily protocol with gradual titration.

  • Peptide Vials (KLOW, 80 mg each):
    • 8 weeks ≈ 3 vials
    • 12 weeks ≈ 4 vials
    • 16 weeks ≈ 5 vials